Public Market

IPO

IPOs of Exxaro Tiles, Krsnaa Diagnostics, Devyani Intl and Windlas Biotech oversubscribed

Mint  

The IPOs of four companies — Exxaro Tiles, Krsnaa Diagnostics, Devyani International, Windlas Biotech — were fully subscribed. Devyani's was subscribed the most, at 116.7 times, followed by Krsnaa Diagnostics (64.4 times), Exxaro Tiles (22.6 times) and Windlas Biotech (22.6 times). The IPOs of four companies — Exxaro Tiles, Krsnaa Diagnostics, Devyani International, Windlas Biotech — were fully subscribed. Devyani's was subscribed the most, at 116.7 times, followed by Krsnaa Diagnostics (64.4 times), Exxaro Tiles (22.6 times) and Windlas Biotech (22.6 times). The INR 1,838 crore IPO of Devyani International received bids for 13.14 billion shares, against the issue size of 112.57 million shares. The retail investors' portion was subscribed 39.39 times. The portion set aside for non-institutional investors was subscribed 213.06 times and that of employees 4.70 times, while qualified institutional buyers put in bids for 95.27 times of their reserved portion. Krsnaa Diagnostics received bids for 458.01 million equity shares over the IPO against an offer size of 7.11 million equity shares. The retail investors' portion was oversubscribed by 42.04 times, non -institutional investor's portion subscribed 116.3 times, and qualified institutional investors bought 49.83 of their reserved portion and the employee portion was subscribed 98%. The Exxaro offer received bids for 25.75 crore equity shares against the IPO size of 1.14 crore equity shares. The portion set aside for retail investors was subscribed 39.92 times. The portion set aside for non-institutional investors was subscribed 5.36 times and that of employees 2.53 times, while qualified institutional buyers put in bids 17.67 times their reserved portion. Windlas Biotech's share sale received bids for 138.52 million equity shares against the IPO size of 6.14 million equity shares. The portion set aside for retail investors was subscribed 24.54 times and that of non-institutional investors witnessed 15.91 times, while qualified institutional investors subscribed 24.1 times their bids for the public issue.